Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2025 Apr;42(4):373-380.
doi: 10.1007/s40266-025-01196-3. Epub 2025 Mar 11.

Trazodone and Risk of Orthostatic Hypotension, Syncope and Falls in Geriatric Outpatients with Hypertension

Affiliations
Observational Study

Trazodone and Risk of Orthostatic Hypotension, Syncope and Falls in Geriatric Outpatients with Hypertension

Giulia Rivasi et al. Drugs Aging. 2025 Apr.

Abstract

Introduction: In older adults, trazodone is frequently prescribed for anxiety and insomnia owing to its perceived greater tolerability in comparison with benzodiazepines. However, it may have hypotensive effects.

Aim: The aim of this study is to investigate the effects of trazodone on orthostatic blood pressure (BP) response and risk of syncope and falls in hypertensive older adults.

Patients and methods: A longitudinal observational study involving patients ≥ 75 years was conducted in two geriatric outpatient clinics in Florence, Italy. At baseline, participants underwent a 3-min active stand test, office BP measurement and home and ambulatory BP monitoring. At follow-up, syncope and falls were recorded.

Results: Among 123 participants (mean age 81 years, 59% female), 12 (10%) reported regular trazodone use. Trazodone users showed lower office diastolic BP (71.8 versus 80.1 mmHg, p = 0.042), a greater systolic and diastolic BP reduction immediately after standing (ΔsystolicT0 23.8 versus 14.3 mmHg, p = 0.037; ΔdiastolicT0 8.9 versus 1.6 mmHg, p = 0.004) and a greater diastolic BP reduction after 1-min standing (ΔdiastolicT1 6.5 versus 0 mmHg, p = 0.029). No differences were reported for home or ambulatory BP. Incidence of syncope and falls was 25%, with a significantly higher rate in patients receiving trazodone (58.3% versus 21.2%, p = 0.001). Trazodone use predicted syncope and falls independently of age, disability and fall history. This association was not confirmed when adjusting for dementia diagnosis. BP values were not associated with the study outcome.

Conclusions: In older hypertensive outpatients, trazodone is associated with a greater orthostatic BP drop and may predispose them to an increased risk of syncope and falls.

PubMed Disclaimer

Conflict of interest statement

Declarations. Funding: The study was supported by Fondazione Cassa di Risparmio di Firenze. We acknowledge co-funding from the European Union – Next Generation EU. Views and opinions expressed are those of the authors only and do not necessarily reflect those of the European Union or the European Commission. Neither the European Union nor the European Commission can be held responsible for them (PNRR MUR M4 C2 Inv. 1.5 CUP B83C22003920001). Conflicts of Interest: Giulia Rivasi, Marco Capacci, Lorenzo Maria Del Re, Ilaria Ambrosino, Ludovica Ceolin, Alessandra Liccardo, Maria Francesca Bisignano, Giuseppe D’Ambrosio, Greta Ceccarelli, Giulia Matteucci, Enrico Mossello, and Andrea Ungara declare that they have no potential conflicts of interest that might be relevant to the contents of this manuscript. Availability of Data and Material: The data that support the findings of this study are available from the corresponding author upon reasonable request. Ethics Approval: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the local research ethics committee (protocol number: 16539_oss). Consent to Participate: Informed consent was obtained from all individual participants or his/her legal representative included in the study. Consent for Publication: Not applicable. Code Availability: Not applicable. Author Contributions: Conceptualization: Giulia Rivasi, Andrea Ungar, Enrico Mossello, and Marco Capacci. Acquisition, analysis, or interpretation of data: all authors. Writing – original draft preparation: Giulia Rivasi, Andrea Ungar, Enrico Mossello, Marco Capacci, and Lorenzo Del Re. Writing – review and editing: all authors. All authors read and approved the final version.

Figures

Fig. 1
Fig. 1
Systolic (left panel) and diastolic (right panel) blood pressure values during active standing by trazodone use. Error bars represent 95% confidence intervals
Fig. 2
Fig. 2
Kaplan–Meier curves for the composite outcome of syncope and falls, stratified by trazodone use (log-rank test p = 0.001)

References

    1. Italian Medicines Agency (2021) The Medicines Utilisation Monitoring Centre. National report on medicines use in older adults in Italy. Year 2019. https://www.aifa.gov.it/-/rapporto-osmed-2019 (accessed on Oct 13, 2024)
    1. Wong J, Murray Horwitz M, Bertisch SM, et al. Trends in dispensing of zolpidem and low-dose trazodone among commercially insured adults in the United States, 2011–2018. JAMA. 2020;324:2211. - PMC - PubMed
    1. Coin A, Noale M, Gareri P, et al. GeroCovid Observational Working Group. Clinical profile of trazodone users in a multisetting older population: data from the Italian GeroCovid Observational study. Eur Geriatr Med. 2023;14(3):465–76. - PMC - PubMed
    1. Fagiolini A, Comandini A, Dell’Osso MC, Kasper S. Rediscovering trazodone for the treatment of major depressive disorder. CNS Drugs. 2012;26:1033–49. 10.1007/s40263-012-0010-5. - PMC - PubMed
    1. Calvi A, Fischetti I, Verzicco I, et al. Antidepressant drugs effects on blood pressure. Front Cardiovasc Med. 2021. 10.3389/fcvm.2021.704281. - PMC - PubMed

Publication types

LinkOut - more resources